Vincerx Pharma Inc (VINC)
0.325
-0.01
(-4.24%)
USD |
NASDAQ |
Nov 13, 16:00
0.3187
-0.01
(-1.94%)
After-Hours: 20:00
Vincerx Pharma Price to Book Value: 0.6242 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.6242 |
| November 12, 2024 | 0.6519 |
| November 11, 2024 | 0.6759 |
| November 08, 2024 | 0.6287 |
| November 07, 2024 | 0.6189 |
| November 06, 2024 | 0.6281 |
| November 05, 2024 | 0.6646 |
| November 04, 2024 | 0.6876 |
| November 01, 2024 | 0.7011 |
| October 31, 2024 | 0.6703 |
| October 30, 2024 | 0.6723 |
| October 29, 2024 | 0.7107 |
| October 28, 2024 | 0.7155 |
| October 25, 2024 | 0.7299 |
| October 24, 2024 | 0.7433 |
| October 23, 2024 | 0.6992 |
| October 22, 2024 | 0.7416 |
| October 21, 2024 | 0.7262 |
| October 18, 2024 | 0.7299 |
| October 17, 2024 | 0.7251 |
| October 16, 2024 | 0.7645 |
| October 15, 2024 | 0.7297 |
| October 14, 2024 | 0.7779 |
| October 11, 2024 | 0.7529 |
| October 10, 2024 | 0.7441 |
| Date | Value |
|---|---|
| October 09, 2024 | 0.7683 |
| October 08, 2024 | 0.7827 |
| October 07, 2024 | 1.341 |
| October 04, 2024 | 1.402 |
| October 03, 2024 | 1.374 |
| October 02, 2024 | 1.332 |
| October 01, 2024 | 1.316 |
| September 30, 2024 | 1.375 |
| September 27, 2024 | 1.316 |
| September 26, 2024 | 1.344 |
| September 25, 2024 | 1.326 |
| September 24, 2024 | 1.454 |
| September 23, 2024 | 1.384 |
| September 20, 2024 | 1.403 |
| September 19, 2024 | 1.343 |
| September 18, 2024 | 1.321 |
| September 17, 2024 | 1.349 |
| September 16, 2024 | 1.344 |
| September 13, 2024 | 1.353 |
| September 12, 2024 | 1.362 |
| September 11, 2024 | 1.326 |
| September 10, 2024 | 1.364 |
| September 09, 2024 | 1.418 |
| September 06, 2024 | 1.371 |
| September 05, 2024 | 1.441 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2284
Minimum
Dec 09 2022
15.38
Maximum
Mar 11 2024
2.799
Average
1.152
Median
Jun 30 2023
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.573 |
| AIM ImmunoTech Inc | 2.511 |
| IGC Pharma Inc | 3.525 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 3.191 |
Price to Book Value Related Metrics
| Price | 0.325 |
| Earnings Yield | -406.2% |
| Market Cap | 9.643M |